Passage BIO, Inc.·4

Jul 21, 6:54 PM ET

Toernsen Monika Maria 4

4 · Passage BIO, Inc. · Filed Jul 21, 2021

Insider Transaction Report

Form 4
Period: 2021-07-19
Toernsen Monika Maria
Chief Commercial Officer
Transactions
  • Award

    Restricted Stock Units

    2021-07-19+20,00020,000 total
    Common Stock (20,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2021-07-19+200,000200,000 total
    Exercise: $13.04Exp: 2031-07-18Common Stock (200,000 underlying)
Footnotes (3)
  • [F1]The option vests as to 25% of the total shares on July 19, 2022, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on July 19, 2024, subject to the Reporting Person's provision of service to the issuer on each vesting date.
  • [F2]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F3]1/4 of the RSUs will vest annually on September 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION